NEW ENTERPRISE ASSOCIATES 14, L.P. - GALERA THERAPEUTICS, INC. -- SCHEDULE 13G

Company

Galera Therapeutics, Inc.

Filed

February 13, 2020

Accession Number

0001072613-20-000090

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →